Dyserythropoietic Anemia and Thrombocytopenia Latest Advances

Find the Latest Research About Dyserythropoietic Anemia and Thrombocytopenia

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 576 publications

Identification of a Novel Compound Heterozygous SEC23B in a Chinese Child with Congenital Dyserythropoietic Anemia Type II.

Identification of a Novel Compound Heterozygous SEC23B in a Chinese Child with Congenital Dyserythropoietic Anemia Type II.

Journal: Hemoglobin
Published: August 04, 2026

Double Heterozygous CDAN1 Variants of Uncertain Significance Associated With a Phenotype Consistent With Congenital Dyserythropoietic Anemia Type 1.

Double Heterozygous CDAN1 Variants of Uncertain Significance Associated With a Phenotype Consistent With Congenital Dyserythropoietic Anemia Type 1.

Journal: Case reports in hematology
Published: April 18, 2026

KLF1 mutation-associated congenital dyserythropoietic anemia type IV: a case report and literature review.

KLF1 mutation-associated congenital dyserythropoietic anemia type IV: a case report and literature review.

Journal: Frontiers in pediatrics
Published: April 13, 2026

LSD1 inhibition ameliorates congenital dyserythropoietic anemia type II.

LSD1 inhibition ameliorates congenital dyserythropoietic anemia type II.

Journal: Science translational medicine
Published: March 25, 2026

Murine model for Congenital Dyserythropoietic Anemia Type I.

Murine model for Congenital Dyserythropoietic Anemia Type I.

Journal: Blood advances
Published: March 10, 2026

A novel homozygous C15ORF41 variant (c.251T > A; p.Val84Glu) causing congenital dyserythropoietic anemia type Ib in an Indian patient: molecular and structural evidence.

A novel homozygous C15ORF41 variant (c.251T > A; p.Val84Glu) causing congenital dyserythropoietic anemia type Ib in an Indian patient: molecular and structural evidence.

Journal: Molecular biology reports
Published: March 06, 2026

Case Report: HCV-triggered porphyria cutanea tarda in a patient with SEC23B-mutated congenital dyserythropoietic anemia type II.

Case Report: HCV-triggered porphyria cutanea tarda in a patient with SEC23B-mutated congenital dyserythropoietic anemia type II.

Journal: Frontiers in medicine
Published: February 25, 2026

Congenital Dyserythropoietic Anemia Type II Caused by a New SEC23B Sequence Variant.

Congenital Dyserythropoietic Anemia Type II Caused by a New SEC23B Sequence Variant.

Journal: Case reports in hematology
Published: December 26, 2025

Using Patient Feedback to Improve Treatment Outcomes for Patients with Congenital Dyserythropoietic Anaemia Type I Receiving Interferon Therapy.

Using Patient Feedback to Improve Treatment Outcomes for Patients with Congenital Dyserythropoietic Anaemia Type I Receiving Interferon Therapy.

Journal: Journal of clinical medicine
Published: November 25, 2025

Anemia-associated mutations disrupt the CDIN1-Codanin1 complex in inherited congenital dyserythropoietic anemia I (CDA-I) disease.

Anemia-associated mutations disrupt the CDIN1-Codanin1 complex in inherited congenital dyserythropoietic anemia I (CDA-I) disease.

Journal: The FEBS journal
Published: September 01, 2025

Haploidentical hematopoietic stem cell transplantation for the treatment of congenital dyserythropoietic anemia combined with thalassemia: a report of two cases.

Haploidentical hematopoietic stem cell transplantation for the treatment of congenital dyserythropoietic anemia combined with thalassemia: a report of two cases.

Journal: Annals of hematology
Published: May 24, 2025

Angioid streaks and optic disc drusen in a patient with congenital dyserythropoietic anaemia.

Angioid streaks and optic disc drusen in a patient with congenital dyserythropoietic anaemia.

Journal: BMJ case reports
Published: May 23, 2025
Showing 1-12 of 576

Last Updated: 09/26/2026